Cutler Group LP Acurx Pharmaceuticals, Inc. Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
A detailed history of Cutler Group LP transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 1,200 shares of ACXP stock, worth $2,856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200
Previous 2,300
47.83%
Holding current value
$2,856
Previous $8,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
30Shares Held
1.25MCall Options Held
16.1KPut Options Held
33.8K-
Vanguard Group Inc Valley Forge, PA492KShares$1.17 Million0.0% of portfolio
-
Prospect Financial Services LLC Melville, NY273KShares$649,3830.55% of portfolio
-
Geode Capital Management, LLC Boston, MA116KShares$276,9170.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ57.3KShares$136,2550.0% of portfolio
-
State Street Corp Boston, MA43.5KShares$103,4490.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $27.5M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...